The advent of big data technologies has revolutionized cancer research. High-throughput sequencing, large-scale clinical trials, and extensive epidemiological studies generate vast amounts of data. Artificial intelligence and machine learning algorithms are increasingly used to uncover patterns and generate predictive models, facilitating the development of personalized medicine and novel therapeutic strategies.